Copyright
©The Author(s) 2022.
World J Gastrointest Endosc. May 16, 2022; 14(5): 320-334
Published online May 16, 2022. doi: 10.4253/wjge.v14.i5.320
Published online May 16, 2022. doi: 10.4253/wjge.v14.i5.320
Figure 5 Relationship between muscle layer defect angle measurements and clinicopathological factors.
A: Pre-muscle layer defect angle (MDA) not correlated with preoperative treatment [neoadjuvant chemotherapy (NAC) vs chemoradiotherapy (CRT)]; B: Post-MDA not correlated with preoperative treatment (NAC vs CRT); C: MDA reduction rate not correlated with preoperative treatment (NAC vs CRT); D: Pre-MDA correlated with pT (pT0/1 vs pT2/3); E: Post-MDA correlated with pT (pT0/1 vs pT2/3); F: MDA reduction rate correlated with pT (pT0/1 vs pT2/3).
- Citation: Yonemoto S, Uesato M, Nakano A, Murakami K, Toyozumi T, Maruyama T, Suito H, Tamachi T, Kato M, Kainuma S, Matsusaka K, Matsubara H. Why is endosonography insufficient for residual diagnosis after neoadjuvant therapy for esophageal cancer? Solutions using muscle layer evaluation. World J Gastrointest Endosc 2022; 14(5): 320-334
- URL: https://www.wjgnet.com/1948-5190/full/v14/i5/320.htm
- DOI: https://dx.doi.org/10.4253/wjge.v14.i5.320